In breast cancer cells, it induces FOXO3a expression by inhibiting PI3K/Akt and, consequently, upregulates the expression of tumor suppressor proteins, such as the p21, CIP/WAF, and KIP1, thereby resulting in cell-cycle arrest and apoptosis [72]. Here, AKT1 is linked to breast carcinoma.